Kyowa Hakko Europe
Trending Articles
Related Content
Ingredients
Kyowa Hakko and Wellex pair up to launch female-focused Creatine Well
The duo debuted the precision-formulated product that combines Cognizin, Pürest Creatine and Sharp-PS Phosphatidylserine into a fully dissolvable, unflavoured powder targeted towards women's physiology and brain health
Research & Development
Kyowa Hakko to unveil new Cognizin research on acute cognitive effects at ISSN 2026
Kyowa Hakko will present proof-of-concept research at the ISSN Annual Conference exploring the acute effects of a single 500 mg dose of Cognizin Citicoline on brain activity, cognitive performance and mood in healthy adults
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Cognitive
Kyowa Hakko to present Cognizin citicoline brain health science at CMA Innovation Day in Sydney
The firm will spotlight its TGA-registered Cognizin citicoline ingredient at Complementary Medicines Australia Innovation Day 2026, presenting clinical evidence for its role in cognitive performance and long-term brain health to the Australian supplement market